drugset / Trial / NCT01629199
Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this clinical trial is to evaluate the safety and efficacy of rhEGF (recombinant human Epidermal Growth Factor) in diabetic foot ulcer patients with uncontrolled diabetes mellitus.
Timeline
- Start
- 2010-10
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NEPIDERMIN | Protein / enzyme biologic | — | — |
Indications
No indication recorded.